Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Ray Starling served as Sonny Perdue’s Chief of Staff and was an ag advisor during Trump’s first term. He weighs in on Trump’s ag secretary pick, Brooke Rollins of Texas.
“There is a lot that I have to learn on this and if confirmed this will be... one of the very top priorities.”
The farm sector heard key priorities from USDA Secretary nominee Brooke Rollins during her confirmation hearing before the Senate Ag Committee.
